PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Medical » Omni Health, Inc. Reports $1.0M Net Income and a $1.6M Consolidated Proforma Income for 1st Quarter of Fiscal Year 2017

Omni Health, Inc. Reports $1.0M Net Income and a $1.6M Consolidated Proforma Income for 1st Quarter of Fiscal Year 2017

by PublicWire
April 27, 2019
in Medical
Reading Time: 2 mins read
0

MIAMI, FL–OMHE, (Marketwired – Jan 23, 2017) – Omni Health, Inc. (OTC PINK: OMHE), a pharmaceutical company, filed today its first quarter results for fiscal year 2017, ending July 31, 2016. OMHE recorded a $1.08M net income, which incorporated Malecon Pharmacy, Inc., a wholly owned subsidiary of OMHE as of June 22, 2016. In addition to the results, and in accordance with ASC 805-10-50, the Company provided the results of net income of the combined results of the Company’s consolidated operations with the acquisition as if the acquisition had been completed as of the beginning of the reporting period. As such, the proforma results was $1.6M Net Income. The Company recognized a one-time sale of discontinue operations of VitaCig to mCig, Inc. (OTC: MCIG), in the amount of $1.1M leaving a $500K adjusted proforma net income for the consolidated quarter.

OMHE Chief Executive Officer, Andrey Soloviev, stated, “We are in the final stages of becoming current with our filings and will seek immediately to move from OTC Pink to OTCQB. Since the acquisition of Malecon Pharmacy we have been organizing and structuring a 40 year private business into a public market. While our transition has been longer than anticipated, we remain diligent to our shareholders and seek to improve communications with them as we move forward.”

OMHE Interim Chief Financial Officer Michael Hawkins went on to say, “The Company has seen incredible improvement in sales as compared to the same period last year seeing a 767% increase in sales and a 543% increase gross profit.”

Other key financial indicators reported by OMHE included:

  • $5.0M in Assets
  • $233K in Cash
  • $1.3M in Current Assets (cash, accounts receivable, and inventory)
  • $330K in cash provided by operating activities

About Omni Health, Inc.
Headquartered in Miami, Florida, Omni Health Inc. operates a pharmacy operation in Hialeah, Florida, Malecon Pharmacy. Malecon Pharmacy has been a pillar of the local community since 1974 providing healthcare products, pharmacy operations, prescription drugs, and other services and products in the skin care and anti-aging industry.

Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies.

Contact:
Andrey Soloviev
Chief Executive Officer
ysolovei@gmail.com

Tags: Acquisitionhealthcare productsMalecon Pharmacynet incomeOMHEOmni Health Incpharmacy
Previous Post

Nutritional High Announces Inclusion Into U.S. Marijuana Index

Next Post

Aurora Receives Health Canada License to Sell Cannabis Oils

PublicWire

At PublicWire, we know the vast majority of all investors conduct their due diligence and get their news online in a variety of ways including email, social media, financial websites, text messages, RSS feeds and audio/video podcasts. PublicWire’s financial communications program is uniquely positioned to reach these investors throughout the U.S. and Canada as well as on a global scale.

Related Posts

Medical

FDA advisory panel recommends Moderna, Johnson & Johnson vaccine booster shots

October 18, 2021
0
Medical

Walgreens invests $5.5B to accelerate new healthcare business segment

October 18, 2021
0
Medical

Mayo Clinic to study respiratory muscle training as long COVID treatment

October 18, 2021
0
Medical

Anthem, Providence tap Vim for value-based care platform deployment

October 25, 2021
0
Medical

Healthcare lost 17,500 jobs in September amid ongoing labor shortage

October 25, 2021
0
Medical

Cigna divests life, accident and supplemental benefits businesses for $5.75B

October 25, 2021
0
Next Post

Aurora Receives Health Canada License to Sell Cannabis Oils

Please login to join discussion

Subscribe To Our Newsletter

Loading
Ad
PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2022 publicwire.com

Navigate Site

  • About
  • Contact Us
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • Videos

© Copyright 2022 publicwire.com

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.